1
|
Martin-Romera J, Borrego-Marin E, Jabalera-Ortiz PJ, Carraro F, Falcaro P, Barea E, Carmona FJ, Navarro JAR. Organophosphate Detoxification and Acetylcholinesterase Reactivation Triggered by Zeolitic Imidazolate Framework Structural Degradation. ACS Appl Mater Interfaces 2024; 16:9900-9907. [PMID: 38344949 PMCID: PMC10910433 DOI: 10.1021/acsami.3c18855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 01/29/2024] [Accepted: 01/31/2024] [Indexed: 02/15/2024]
Abstract
Organophosphate (OP) toxicity is related to inhibition of acetylcholinesterase (AChE) activity, which plays a key role in the neurotransmission process. In this work, we report the ability of different zinc zeolitic imidazolate frameworks (ZIFs) to behave as potential antidotes against OP poisoning. The Zn-L coordination bond (L = purine, benzimidazole, imidazole, or 2-methylimidazole) is sensitive to the G-type nerve agent model compounds diisopropylfluorophosphate (DIFP) and diisopropylchlorophosphate, leading to P-X (X = F or Cl) bond breakdown into nontoxic diisopropylphosphate. P-X hydrolysis is accompanied by ZIF structural degradation (Zn-imidazolate bond hydrolysis), with the concomitant release of the imidazolate linkers and zinc ions representing up to 95% of ZIF particle dissolution. The delivered imidazolate nucleophilic attack on the OP@AChE adduct gives rise to the recovery of AChE enzymatic function. P-X bond breakdown, ZIF structural degradation, and AChE reactivation are dependent on imidazolate linker nucleophilicity, framework topology, and particle size. The best performance is obtained for 20 nm nanoparticles (NPs) of Zn(2-methylimidazolate)2 (sod ZIF-8) exhibiting a DIFP degradation half-life of 2.6 min and full recovery of AChE activity within 1 h. 20 nm sod ZIF-8 NPs are not neurotoxic, as proven by in vitro neuroblastoma cell culture viability tests.
Collapse
Affiliation(s)
- Javier
D. Martin-Romera
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| | - Emilio Borrego-Marin
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| | - Pedro J. Jabalera-Ortiz
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| | - Francesco Carraro
- Institute
of Physical and Theoretical Chemistry, TU
Graz, Stremayrgasse 9, Graz A-8010, Austria
| | - Paolo Falcaro
- Institute
of Physical and Theoretical Chemistry, TU
Graz, Stremayrgasse 9, Graz A-8010, Austria
| | - Elisa Barea
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| | - Francisco J. Carmona
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| | - Jorge A. R. Navarro
- Departamento
de Química Inorgánica, Universidad
de Granada, Av. Fuentenueva S/N, Granada 18071, Spain
| |
Collapse
|
2
|
Soriano-Lerma A, García-Burgos M, Alférez MJ, Crespo-Pérez JV, Pérez-Carrasco V, Ortiz-Gonzalez M, Linde-Rodriguez Á, Sanchez-Martin V, Soriano M, Garcia-Salcedo JA, López-Aliaga I. Fermented Goat's Milk Contributes to the Recovery of Iron Deficiency Anemia via Modulation of the Gut Microbiome. J Agric Food Chem 2023; 71:15668-15679. [PMID: 37830350 PMCID: PMC11006235 DOI: 10.1021/acs.jafc.3c05560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Revised: 09/19/2023] [Accepted: 09/29/2023] [Indexed: 10/14/2023]
Abstract
Iron deficiency anemia (IDA) is a global public health concern affecting 1.6 billion people worldwide. The administration of iron supplements during the treatment of IDA adversely affects the intestinal barrier function and the composition and functionality of the intestinal microbiome, both of which are already altered during IDA. For this reason, it is of great interest to develop nutritional strategies aimed at alleviating these gut alterations associated with IDA and its treatment. In this sense, fermented goat's milk (FGM) was studied due to its nutritional quality. Our findings showed that in anemic animals the consumption of a FGM-based diet, compared to a standard diet, had positive modulatory effects on the intestinal microbiome. FGM-based diet restored intestinal dysbiosis, the intestinal barrier functionality, and bacterial translocation, contributing to a more efficient recovery of IDA. Therefore, FGM is a useful nutritional tool to ease intestinal alterations occurring during IDA and during its treatment.
Collapse
Affiliation(s)
- Ana Soriano-Lerma
- Department
of Physiology (Faculty of Pharmacy, Campus Universitario de Cartuja),
Institute of Nutrition and Food Technology “José Mataix
Verdú”, University of Granada, E-18071 Granada, Spain
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Instituto
de Investigación Biosanitaria ibs.GRANADA, E-18012 Granada, Spain
| | - María García-Burgos
- Department
of Physiology (Faculty of Pharmacy, Campus Universitario de Cartuja),
Institute of Nutrition and Food Technology “José Mataix
Verdú”, University of Granada, E-18071 Granada, Spain
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
| | - María José
M. Alférez
- Department
of Physiology (Faculty of Pharmacy, Campus Universitario de Cartuja),
Institute of Nutrition and Food Technology “José Mataix
Verdú”, University of Granada, E-18071 Granada, Spain
| | - Jorge Valentín Crespo-Pérez
- Service
of Anatomical Pathology, Intercenter Regional Unit Granada, University Hospital Virgen de las Nieves, E-18014 Granada, Spain
| | - Virginia Pérez-Carrasco
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Instituto
de Investigación Biosanitaria ibs.GRANADA, E-18012 Granada, Spain
- Microbiology
Unit, University Hospital Virgen de las
Nieves, E-18014 Granada, Spain
| | - Matilde Ortiz-Gonzalez
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Center for
Intensive Mediterranean Agrosystems and Agri-Food Biotechnology (CIAIMBITAL), University of Almeria, E-04120 Almería, Spain
| | - Ángel Linde-Rodriguez
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Instituto
de Investigación Biosanitaria ibs.GRANADA, E-18012 Granada, Spain
- Microbiology
Unit, University Hospital Virgen de las
Nieves, E-18014 Granada, Spain
| | - Victoria Sanchez-Martin
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Instituto
de Investigación Biosanitaria ibs.GRANADA, E-18012 Granada, Spain
- Microbiology
Unit, University Hospital Virgen de las
Nieves, E-18014 Granada, Spain
| | - Miguel Soriano
- Center for
Intensive Mediterranean Agrosystems and Agri-Food Biotechnology (CIAIMBITAL), University of Almeria, E-04120 Almería, Spain
| | - Jose A. Garcia-Salcedo
- GENYO,
Centre for Genomics and Oncological Research: Pfizer/University of
Granada/Andalusian Regional Government, PTS Granada, E-18016 Granada, Spain
- Instituto
de Investigación Biosanitaria ibs.GRANADA, E-18012 Granada, Spain
- Microbiology
Unit, University Hospital Virgen de las
Nieves, E-18014 Granada, Spain
| | - Inmaculada López-Aliaga
- Department
of Physiology (Faculty of Pharmacy, Campus Universitario de Cartuja),
Institute of Nutrition and Food Technology “José Mataix
Verdú”, University of Granada, E-18071 Granada, Spain
| |
Collapse
|